Rothschild Investment LLC Ani Pharmaceuticals Inc Transaction History
Rothschild Investment LLC
- $1.6 Trillion
- Q2 2025
A detailed history of Rothschild Investment LLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Rothschild Investment LLC holds 20 shares of ANIP stock, worth $1,766. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20
Previous 30
33.33%
Holding current value
$1,766
Previous $2.01 Million
35.04%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ANIP
# of Institutions
246Shares Held
20.6MCall Options Held
7.4KPut Options Held
12.4K-
Black Rock Inc. New York, NY2.66MShares$235 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.28MShares$113 Million0.0% of portfolio
-
Global Alpha Capital Management Ltd.862KShares$76.2 Million3.45% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny818KShares$72.3 Million0.03% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il723KShares$63.9 Million0.01% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.54B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...